Condition: Neuropathy · Cancer · Chemotherapeutic Drug - Induced Nephropathy · Sponsor: Indiana University
The purpose of this pilot study is to determine the safety and feasibility of a daily 3-minute hand-held vibration therapy intervention to reduce the severity of CIPN in the hands. The investigators hypothesize that daily vibration therapy can reduce the severity of patient's CIPN in their hands and improve CIPN-related quality of life. The hope is that results from this study will provide early data on the feasibility, efficacy, and most importantly, safety, of daily 3-minute hand-held vibration therapy needed to justify future clinical trials examining vibration therapy as a potential option for treating CIPN in the future.
This description comes directly from the study's public registry record.
Cheri West, RN · 317-278-3021 · chawest@iu.edu
Lacy Slayton · (317) 278-6718 · lslayton@iu.edu
Always discuss trial participation with your own doctor first.
| Indiana University Health West | Avon, Indiana, United States | Recruiting |
| Indiana University Melvin & Bren Simon Cancer Center | Indianapolis, Indiana, United States | Recruiting |
| IU Health Joe & Shelly Schwarz Cancer Center | Indianapolis, Indiana, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04207437